2009 annual financial data
Sarepta Therapeutics 2009 Operating cash flow margin
Direct answer
Operating cash flow margin was -50.04%.
Operating income was -15,507,000 USD and net income was -25,159,000 USD.
Operating cash flow was -8,800,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,585,000 USD
- Operating income
- -15,507,000 USD
- Net income
- -25,159,000 USD
- Operating cash flow
- -8,800,000 USD